multi-omics analysis

AcroCyte Therapeutics, Inc. is a biotechnology company specializing in 3D cell culture technology. Its R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) platform enables scaffold-free expansion of rare cells such as circulating tumor cells (CTCs), biopsy-derived cells, and stem cells. The company offers an end-to-end platform from research tools to clinical diagnostic services, including its Onco-REAL™ clinical service for personalized treatment planning.

Read more

3D cell cultureclinical laboratory servicesCTC culture from blood samplesdrug screeninghigh content imagingmanufacturingorganoid culturescaffold-free cell expansion